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ABSTRACT 
 
Background: The mortality rate of breast cancer patients was relatively high 
80% - 60% while the survival rate was only <40%. High estrogen levels and long-
term exposure were associated with an increased risk of breast cancer. Recent 
studies have reported that estradiol can act independently and contribute to the 
risk of distant metastases in breast cancer patients with negative Estrogen 
Receptor (ER) tumors. The aim of this study was to estimate the estradiol effect 
on remission and survival in breast cancer patients in Dr. Moewardi Hospital, 
Surakarta, Central Java. 
Subjects and Method: This was a cohort study conducted at the Department of 
Surgical Oncology, Dr. Moewardi Hospital, Surakarta, Central Java, from March 
to May 2015. A sample of 303 breast cancer patients was selected for this study 
and followed up until 3 years. The independent variable was estradiol level. The 
dependent variables were remission and survival. The data were collected by 
clinical examination and analyzed by Cox Proportional Hazard Model and 
Kapplan-Meier. 
Results: High estradiol level decreased the possibility of remission (HR= 0.31; 
95% CI= 0.09 to 1.11, p= 0.003) in breast cancer patients. Normal estradiol level 
increased survival (HR= 4.03; 95% CI= 1.94 to 8.37; p<0.001). 
Conclusion: High estradiol level decreases the possibility of remission, while 
normal estradiol level increases survival in breast cancer patients. 
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